Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas yet the same is not true for patients with more rare lymphoma types that originate in T cells.
Researchers at Cornell University have developed a powerful new genetic toolkit that allows scientists to study how genes function at the level of individual cells, an advance that could accelerate discoveries in development, neuroscience and disease.
A proof of principle study in mice, six years in the making, shows how targeting a natural checkpoint in meiosis, the process by which sex cells reproduce, safely stopped sperm production.
The class of 2026 learned on March 20 where they will be doing their internship and residency training, setting the stage for the next several years of their medical careers and lives.
Cornell Tech has appointed Tanzeem Choudhury as its Chief of Health Innovation and has formed a new Health Tech Hub Advisory Committee composed of leaders from across the healthcare industry.